×

Acorda CEO: Filed for approval of Diazepam nasal spray

6:15 PM ET Tue, 5 Nov 2013

Acorda Therapeutics president & CEO Dr. Ron Cohen discusses its pipeline and current research, whether epilepsy is an epidemic and its plan for its Diazepam nasal spray.